Clinical trial
Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma
NCT00986037 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma
- Lead sponsor
- AbbVie
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- Not reported
- Enrollment
- 47 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.